Both approaches and further analysis demonstrate that BRCA1 negatively regulates S100A9 in mammary epithelium and the activated S100A9-CXCL12 signaling upon BRCA1 deficiency acts as a driving signaling to establish the tumor microenvironment, which renders tumor cells insensitive to ICB. The gene discussed is CXCL12; the disease is neoplasm.